Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 2/20 | 0.41 |
| ▸ | MPO | P05164 | 1/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21205152 | 0.83 | TAAR1 (0.45) | TAAR1IDO1MPO | |
| SCHEMBL1263547 | 0.76 | TAAR1 (0.60) | TAAR1LTA4HIDO1DAOACHE | |
| SCHEMBL29459538 | 0.76 | TAAR1 (0.60) | TAAR1LTA4HIDO1DAOACHE | |
| SCHEMBL30000562 | 0.76 | TAAR1 (0.60) | TAAR1LTA4HIDO1DAOACHE | |
| SCHEMBL8094710 | 0.76 | TAAR1 (0.47) | TAAR1IDO1DAOMPOACHE | |
| SCHEMBL2094961 | 0.73 | TAAR1 (0.48) | TAAR1IDO1DAOMPOACHE | |
| SCHEMBL27806708 | 0.73 | TAAR1 (0.44) | TAAR1LTA4HIDO1DAOMPO | |
| SCHEMBL6560649 | 0.73 | ABL1 (0.49) | TAAR1LTA4HIDO1DAOABL1 | |
| SCHEMBL17398826 | 0.72 | TAAR1 (0.41) | TAAR1LTA4HIDO1DAOMPO | |
| SCHEMBL8093804 | 0.72 | TAAR1 (0.56) | TAAR1LTA4HIDO1DAOACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106999479-A | It can be used as the heteroaryl compound of SUMO activating enzyme inhibitors | 米伦纽姆医药公司 | 2017-08-01 | — | — | CN | disclosed |